Table 1.
Nutrition information and amino acid profile of GLU, GLU + 10g-PP, GLU + 20g-PP, GLU + 10g-WP and GLU + 20g-WP consumed in the study.
Table 2.
Physical characteristics of the included study population (mean ± SD).
Fig 1.
CONSORT 2025 flow diagram of the progress through the phases of the randomised crossover trial of one group.
Fig 2.
GR curves for GLU, GLU + 10g-PP, GLU + 20g-PP, GLU + 10g-WP and GLU + 20g-WP. Data are presented as mean and SEM (n 30). GLU (Glucose), GLU + 10g-PP (Glucose + 10g NUTRALYS® S85 Plus Pea Protein), GLU + 20g-PP (Glucose + 20g NUTRALYS® S85 Plus Pea Protein), GLU + 10g-WP (Glucose + 10g Whey Protein Concentrate) and GLU + 20g-WP (Glucose + 20g Whey Protein Concentrate). SEM, standard error of the mean.
Table 3.
Mean (± SD) iAUC blood glucose (mmol/l*min) at 60, 90, 120 and 180 minutes after consumption of GLU, GLU + 10g-PP, GLU + 20g-PP, GLU + 10g-WP and GLU + 20g-WP.
Fig 3.
IR curves for GLU, GLU + 10g-PP, GLU + 20g-PP, GLU + 10g-WP and GLU + 20g-WP. Data are presented as mean and SEM (n 30). GLU (Glucose), GLU + 10g-PP (Glucose + 10g NUTRALYS® S85 Plus Pea Protein), GLU + 20g-PP (Glucose + 20g NUTRALYS® S85 Plus Pea Protein), GLU + 10g-WP (Glucose + 10g Whey Protein Concentrate) and GLU + 20g-WP (Glucose + 20g Whey Protein Concentrate). SEM, standard error of the mean.
Table 4.
Mean (± SD) iAUC plasma insulin (µU/ml*min) at 60, 90, 120 and 180 minutes after consumption of GLU, GLU + 10g-PP, GLU + 20g-PP, GLU + 10g-WP and GLU + 20g-WP.